BSEBoard Meeting5 Aug 2026 · 5 Aug 2026, 05:17 pm
Outcome of the Board Meeting - Unaudited Financial Results (standalone and consolidated) for the first quarter ended 30 June 2026
Aster DM Quality Care Ltd · 540975
✦ AI SummaryResults
Aster DM Quality Care Ltd has announced its unaudited financial results for the first quarter ended 30 June 2026, with the Board of Directors approving the results as reviewed and recommended by the Audit Committee. The results will be published in newspapers as required under the Listing Regulations.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Aster DM Quality Care Ltd - 540975 - Board Meeting Outcome for Outcome Of The Board Meeting - Unaudited Financial Results (Standalone And Consolidated) For The First Quarter Ended 30 June 2026
Attachments (1)
📄pdf
Download →
a122fae4-5403-490e-a2be-8fe71c18bfae.pdf
View document text
5 August 2026
BSE Limited The National Stock Exchange of India Limited
Phiroze Jeejeebhoy Towers, Exchange Plaza, Bandra Kurla Complex,
Dalal Street, Mumbai 400001, Bandra (East), Mumbai 400051,
Maharashtra, India Maharashtra, India
Scrip Code: 540975 Scrip Symbol: ASTERDM
Dear Sir/Madam,
Subject: Outcome of the Board Meeting - Unaudited Financial Results (standalone and consolidated)
for the first quarter ended 30 June 2026
Ref: Regulation 30 and 33 of SEBI (Listing Obligation and Disclosure Requirements) Regulations,
2015 (“Listing Regulations”)
With reference to our letter dated 30 July 2026 and in accordance with Regulation 30 and 33 of the
Listing Regulations, we wish to inform you that the Board of Directors of Aster DM Quality Care Limited
(formerly known as Aster DM Healthcare Limited) (“the Board” and “the Company”, respectively) at its
meeting held today i.e. 5 August 2026, inter alia, has approved the unaudited financial results
(standalone and consolidated) of the Company for the quarter ended 30 June 2026 (“UFRs”), as reviewed
and recommended by the Audit Committee. A copy of UFRs, along with the limited review report
thereon issued by M/s. Deloitte Haskins & Sells, Statutory Auditors are enclosed. The UFRs shall be
published in the newspapers as required under the Listing Regulations.
The Meeting of the Board of Directors commenced at 11:30 AM (IST) and concluded at 04:40 PM (IST).
The above information will also be hosted on the website of the Company i.e.
www.asterqualitycare.com
This is for your information and records.
Thanking you,
For Aster DM Quality Care Limited
(Formerly known as Aster DM Healthcare Limited)
Hemish Purushottam
Company Secretary and Compliance Officer
M. No. A24331
Aster DM Quality Care Limited
(Formerly Aster DM Healthcare Limited)
Registered Office: No 7-1-450/20, Plot No-04, Mythri Vihar, Sanjeev CIN: L85110TS2008PLC207383
Reddy Nagar, Ameerpet, Hyderabad, Telangana, India, 500038 Telephone: +91 96060 61833
E-mail: cs@asterqualitycare.com
Corporate Office: Brigade Deccan Heights 20th & 12th Floor, Website: www.asterqualitycare.com
#42, 5th Mile, Tumkur Rd, Yeshwanthpur Industrial Area, Phase 1,
Yeshwanthpur, Bengaluru-560022
Chartered Accountants
Prestige Trade Tower, Level 19
46, Palace Road, High Grounds
Bengaluru 560 001
Karnataka, India
Tel: +91 8061886000
Fax: +91 806188 6011
UNAUDITED STANDALONE FINANCIAL RESULTS
TO THE BOARD OF DIRECTORS OF ASTER DM QUALITY CARE LIMITED (formerly
known as ASTER DM HEALTHCARE LIMITED)
1. We have reviewed the accompanying Statement of Unaudited Standalone Financial
Results of ASTER DM QUALITY CARE LIMITED (formerly known as ASTER DM
HEALTHCARE LIMITED) interim financial
) for the
quarter ended 30 June 2026
pursuant to the requirement of Regulation 33 of the SEBI (Listing Obligations and
Disclosure Requirements) Regulations, 2015, as amended .
the recognition and measurement principles laid down in the Indian Accounting
of the Companies Act, 2013 read with relevant rules issued thereunder and other
accounting principles generally accepted in India. Our responsibility is to express a
conclusion on the Statement based on our review.
3. We conducted our review of the Statement in accordance with the Standard on Review
India (ICAI). A review of interim financial information consists of making inquiries,
and applying analytical and other review procedures. A review is substantially less in
scope than an audit conducted in accordance with Standards on Auditing specified
under section 143(10) of the Companies Act, 2013 and consequently does not enable
us to obtain assurance that we would become aware of all significant matters that
might be identified in an audit. Accordingly, we do not express an audit opinion.
We also performed procedures in accordance with the circular issued by the SEBI under
Regulation 33(8) of the SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015, as amended, to the extent applicable.
4. Based on our review conducted as stated in paragraph 3 above, nothing has come to
our attention that causes us to believe that the accompanying Statement, prepared in
accordance with the recognition and measurement principles laid down in the aforesaid
Indian Accounting Standard and other accounting principles generally accepted in
India, has not disclosed the information required to be disclosed in terms of the Listings
Regulations, including the manner in which it is to be disclosed, or that it contains any
material misstatement.
5. The Unaudited Standalone Financial Results includes the interim financial information
of the ESOP trust which have not been reviewed by its auditor whose interim financial
information reflect total revenue of INR 0.56 crores, total net profit after tax of INR
0.42 crores and total comprehensive income of INR 0.42 crores for the quarter ended
30 June 2026, as considered in the Statement. According to the information and
explanations given to us by the Management, these interim financial information are
not material to the Company.
Our conclusion on the Statement is not modified in respect of our reliance on the
interim financial information certified by the Management.
For Deloitte Haskins & Sells
Chartered Accountants
008072S)
Ankit Daga
(Partner)
(Membership No. 512486)
(UDIN: 26512486AFXMIV2992)
Place: Bengaluru
Date: 5 August 2026
Page 2 of 2
Aster DM Quality Care Limited
(Formerly known as Aster DM Healthcare Limited)
CIN : L85110TS2008PLC207383
Registered office : No 7-1-450/20, Plot No-04, Mythri Vihar, Sanjeev Reddy Nagar, Ameerpet, Hyderabad, Telangana, India, 500038
Statement of Unaudited Standalone Financial Results for the quarter ended 30 June 2026
(Amount in INR crores)
Quarter ended Year ended
Particulars 30 June 2026 31 March 2026 30 June 2025 31 March 2026
(refer Note 9)
(Unaudited) (Audited)
1 Income
Revenue from operations 725.73 655.10 613.04 2,615.70
Other income 39.03 40.55 38.43 155.03
Total income 764.76 695.65 651.47 2,770.73
2 Expenses
Purchase of medicines and medical consumables 162.04 122.14 130.46 530.68
Changes in inventories (12.28) 8.15 ( 0.56) 8.49
Professional fees to consultant doctors 165.48 149.99 136.22 579.85
Laboratory outsourcing charges 21.91 18.98 17.92 78.55
Employee benefits expense 121.39 103.94 91.48 403.45
Finance costs 24.02 20.98 21.64 87.27
Depreciation and amortisation expenses 41.32 37.57 37.88 154.02
Other expenses 120.20 113.53 104.01 464.30
Total expenses 644.08 575.28 539.05 2,306.61
3 Profit before exceptional items and tax (1-2) 120.68 120.37 112.42 464.12
4 Exceptional items (refer Note 7) ( 109.79) (77.73) ( 4.39) (89.92)
5 Profit before tax (3+4) 10.89 42.64 108.03 374.20
6 Tax expenses
Current tax 35.12 19.93 28.87 124.37
Deferred tax (9.93) (4.75) ( 1.43) (17.99)
Total tax expense 25.19 15.18 27.44 106.38
7 Profit/(Loss) for the period / year (5-6) (14.30) 27.46 80.59 267.82
8 Other comprehensive income/(loss) for the period /
year
Itemsthatwillnotbereclassifiedsubsequentlytoprofit
or loss
Remeasurement of net defined benefit liability - 1.18 - (0.21)
Incometaxrelatingtoitemsthatwillnotbereclassified - (0.30) - 0.05
to profit or loss
Other comprehensive income/(loss), net of taxes - 0.88 - (0.16)
9 Total comprehensive income/(loss) (7+8) (14.30) 28.34 80.59 267.66
10 Paid-up equity share capital (Face value of INR 10 518.13 518.13 518.13 518.13
each)
11 Other equity 3,848.09
12 Earnings/(Loss) per share (Face value of INR 10 each) Not annualised Not annualised Not annualised Annualised
Basic (in INR) (0.28) 0.53 1.58 5.20
Diluted (in INR) (0.28) 0.53 1.57 5.19
See accompanying notes to the Statement of Unaudited Standalone Financial Results
Aster DM Quality Care Limited
(Formerly known as Aster DM Healthcare Limited)
CIN : L85110TS2008PLC207383
Registered office : No 7-1-450/20, Plot No-04, Mythri Vihar, Sanjeev Reddy Nagar, Ameerpet, Hyderabad, Telangana, India, 500038
Notes to the Statement of Unaudited Standalone Financial Results:
1) TheStatemento
[Showing first 8,000 characters — download PDF for full document]